CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Park Sam Boong Chief Operating Officer | Grant or award | −151,869 | 265,168 | ||
| 2024-02-14 | Badawi Paul President and CEO | Grant or award | −390,187 | 5,763,300 | ||
| 2024-02-14 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award | −151,869 | 173,513 | ||
| 2024-02-14 | Bauerlein Alison Chief Financial Officer | Grant or award | −315,421 | 436,371 | ||
| 2024-01-17 | Badawi Paul President and CEO | Sale | −15,917 | $5.16 | $82K | 5,319,539 |
| 2024-01-17 | Badawi David Chief Technology Officer | Sale | −3,414 | $5.16 | $18K | 1,642,157 |
| 2024-01-17 | HAYDEN JEREMY B. Chief Legal Officer | Sale | −4,538 | $5.16 | $23K | 10,318 |
| 2024-01-17 | Park Sam Boong Chief Operating Officer | Sale | −5,443 | $5.16 | $28K | 100,735 |
| 2024-01-03 | Badawi David Chief Technology Officer | Shares withheld for taxes | −2,425 | $5.17 | $13K | 1,645,571 |
| 2024-01-03 | Badawi Paul President and CEO | Shares withheld for taxes | −8,975 | $5.17 | $46K | 5,335,456 |
| 2024-01-03 | HAYDEN JEREMY B. Chief Legal Officer | Shares withheld for taxes | −1,227 | $5.17 | $6K | 14,856 |
| 2024-01-03 | Park Sam Boong Chief Operating Officer | Shares withheld for taxes | −2,464 | $5.17 | $13K | 106,178 |
| 2023-12-27 | D1 Capital Partners L.P. 10% owner | Sale | −2,852,036 | $5.86 | $16.7M | 3,000,000 |
| 2023-11-30 | Encrantz Staffan Director | Purchase | +140,777 | $3.46 | $487K | 1,012,150 |
| 2023-11-29 | Encrantz Staffan Director | Purchase | +3,223 | $3.50 | $11K | 871,373 |
| 2023-11-28 | Encrantz Staffan Director | Purchase | +253,669 | $3.46 | $877K | 868,150 |
| 2023-11-27 | Encrantz Staffan Director | Purchase | +246,331 | $3.31 | $816K | 614,481 |
| 2023-11-24 | Encrantz Staffan Director | Purchase | +21,855 | $3.09 | $67K | 368,150 |
| 2023-11-24 | Badawi David Chief Technology Officer | Option exercise | +150,000 | $0.11 | $17K | 1,631,196 |
| 2023-11-24 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −150,000 | $0.11 | $17K | 0 |
Page 9 of 16 · 302 trades